pMBP-AsCas12a Citations (4)

Originally described in: CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.
Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA Science. 2018 Apr 27;360(6387):436-439. doi: 10.1126/science.aar6245. Epub 2018 Feb 15. PubMed Journal

---

Articles Citing pMBP-AsCas12a

Articles
Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a. Knott GJ, Cress BF, Liu JJ, Thornton BW, Lew RJ, Al-Shayeb B, Rosenberg DJ, Hammel M, Adler BA, Lobba MJ, Xu M, Arkin AP, Fellmann C, Doudna JA. Elife. 2019 Aug 9;8. pii: 49110. doi: 10.7554/eLife.49110. PubMed
Optimized protocols for the characterization of Cas12a activities. Martin L, Rostami S, Rajan R. Methods Enzymol. 2023;679:97-129. doi: 10.1016/bs.mie.2022.08.048. PubMed
The engineered CRISPR-Mb2Cas12a variant enables sensitive and fast nucleic acid-based pathogens diagnostics in the field. Jiao J, Liu Y, Yang M, Zheng J, Liu C, Ye W, Song S, Bai T, Song C, Wang M, Shi J, Wan R, Zhang K, Hao P, Feng J, Zheng X. Plant Biotechnol J. 2023 Jul;21(7):1465-1478. doi: 10.1111/pbi.14051. Epub 2023 Apr 17. PubMed
Innate programmable DNA binding by CRISPR-Cas12m effectors enable efficient base editing. Bigelyte G, Duchovska B, Zedaveinyte R, Sasnauskas G, Sinkunas T, Dalgediene I, Tamulaitiene G, Silanskas A, Kazlauskas D, Valancauskas L, Madariaga-Marcos J, Seidel R, Siksnys V, Karvelis T. Nucleic Acids Res. 2024 Apr 12;52(6):3234-3248. doi: 10.1093/nar/gkae016. PubMed

If you have published an article using this material, please email us at to have your article added to this page.